Hepatic arterial chemotherapy (HAC) with oxaliplatin (OXA), leucovorin (LV) and 5-fluorouracil (5FU): A feasible and effective regimen.

被引：0
|
作者：
Del Freo, DFAA
Lombardi, M
Mambrini, A
Muttini, MP
Pennucci, MC
Sanguinetti, F
Torri, T
Cantore, M
机构：
[1] ASL 01 Massa Carrara, Dept Oncol, Carrara, Italy
[2] ASL 01 Massa Carrara, Dept Surg, Carrara, Italy
[3] ASL Massa Carrara, Dept Oncol, Carrara, Italy
[4] ASL 01 Massa Carrara, Dept Radiol, Carrara, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase Ib study of oxaliplatin in combination with fluorouracil (5FU) and leucovorin (LV) in pediatric patients (pts) with advanced solid tumors
    Gore, L.
    Kuttesch, J.
    Hunger, S. P.
    Herzog, C.
    Narendaren, A.
    Boklan, J.
    Foreman, N. K.
    Ivy, S. P.
    Boucher, N.
    Trippett, T. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy
    Siveke, J. T.
    Chen, L-T
    Von Hoff, D. D.
    Li, C-P
    Wang-Gillam, A.
    Bodoky, G.
    Dean, A.
    Shan, Y-S
    Jameson, G.
    Macarulla, T.
    Lee, K-H
    Cunningham, D.
    Blanc, J-F
    Hubner, R. A.
    Chiu, C-F
    Schwartsmann, G.
    Braiteh, F.
    Moyo, V.
    Belanger, B.
    Bayever, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 170 - 170
  • [33] Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma
    Taïeb, J
    Mitry, E
    Boige, V
    Artru, P
    Ezenfis, J
    Lecomte, T
    Clavero-Fabri, MC
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1192 - 1196
  • [34] Unresectable rectal cancer (URC): Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) with concurrent radiotherapy (RT) followed by surgery. Preliminary results.
    Carraro, S
    Roca, E
    Cartelli, C
    Rafailovici, L
    Wasserman, E
    Odena, SC
    Masciangioli, G
    Huertas, E
    Ballarino, G
    Rodriguez, C
    ANNALS OF ONCOLOGY, 2000, 11 : 48 - 48
  • [35] Multiorgan Failure in a Patient Treated With the 5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Regimen
    Schwartzman, Andrew D.
    Sethi, Roshan
    Smith, Roy
    CLINICAL COLORECTAL CANCER, 2013, 12 (02) : 136 - 139
  • [36] Etoposide, leucovorin (LV) and 5-fluorouracil (5-FU) in 5-FU+LV pre-treated patients with advanced colorectal cancer
    Tsavaris, N
    Kosmas, C
    Gennatas, K
    Vadiaka, M
    Skopelitis, E
    Xila, V
    Rokana, S
    Margaris, E
    Zografos, G
    Papastratis, G
    Kouraklis, G
    JOURNAL OF CHEMOTHERAPY, 2002, 14 (04) : 406 - 411
  • [37] Trimetrexate (TMTX) modulation of 5-fluorouracil leucovorin (5-FU/LV) for advanced colorectal cancer
    Blanke, C
    Kasimis, B
    Schein, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 748 - 748
  • [38] Combination of oxaliplatin (OXA) and 5-fluorouracil, leucovorin (5-FU/LV), as first line therapy, in elderly patients >70years, with metastatic colorectal cancer.
    Botto, HG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 298S - 298S
  • [39] A phase I study of ZD 1839 (Iressa) in combination with oxaliplatin, 5-fluorouracil (5-FU) and leucovorin (LV) in advanced solid malignancies
    Fisher, GA
    Cho, CD
    Halsey, JZ
    Advani, RH
    Yuen, AR
    Lum, BL
    Sikic, BI
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S63 - S63
  • [40] A phase I study of oxaliplatin (OXA), 5-fluorouracil (5FU) and concomitant preoperative irradiation in patients with locally advanced rectal cancer.
    Balart, J
    Marcuello, E
    Garriga, J
    Pernas, J
    Sancho, F
    González, D
    Pétriz, L
    Llaurado, J
    Martínez, A
    Guallar, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 304S - 304S
12345